Chemed Co. (NYSE:CHE) Shares Bought by Pathstone Holdings LLC

Pathstone Holdings LLC boosted its holdings in shares of Chemed Co. (NYSE:CHEFree Report) by 6.0% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 3,694 shares of the company’s stock after buying an additional 210 shares during the quarter. Pathstone Holdings LLC’s holdings in Chemed were worth $2,220,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the business. GAMMA Investing LLC increased its holdings in shares of Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust acquired a new position in shares of Chemed in the third quarter valued at about $61,000. Mather Group LLC. increased its holdings in shares of Chemed by 60.5% in the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after purchasing an additional 69 shares during the period. Quarry LP increased its holdings in shares of Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares during the period. Finally, LRI Investments LLC acquired a new position in shares of Chemed in the first quarter valued at about $171,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. StockNews.com lowered Chemed from a “buy” rating to a “hold” rating in a report on Friday, November 22nd. Royal Bank of Canada dropped their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.

Read Our Latest Research Report on Chemed

Insider Buying and Selling at Chemed

In other news, EVP Nicholas Michael Westfall sold 1,713 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the transaction, the executive vice president now owns 6,109 shares in the company, valued at $3,478,159.15. This trade represents a 21.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director George J. Walsh III sold 400 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the transaction, the director now owns 3,046 shares in the company, valued at approximately $1,819,893.62. This trade represents a 11.61 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,113 shares of company stock valued at $3,557,445. Company insiders own 3.32% of the company’s stock.

Chemed Stock Up 0.3 %

Chemed stock opened at $573.57 on Wednesday. The firm has a market cap of $8.63 billion, a price-to-earnings ratio of 28.80, a price-to-earnings-growth ratio of 2.42 and a beta of 0.46. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62. The business’s 50-day moving average price is $578.95 and its 200 day moving average price is $564.99.

Chemed (NYSE:CHEGet Free Report) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same period last year, the business earned $5.32 earnings per share. Equities analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s payout ratio is currently 10.11%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.